苍牛防己黄芪汤联合西医疗法治疗乙肝肝硬化腹水的临床疗效

发布时间：2018-05-05 01:45

本文选题：苍牛防己黄芪汤 + 乙肝肝硬化腹水　；参考：《基因组学与应用生物学》2017年06期

【摘要】：为探究苍牛防己黄芪汤联合西医疗法对乙肝肝硬化腹水患者的临床疗效,本研究以2016年5~10月期间我院收治的64例乙肝肝硬化腹水患者为研究对象,随机分成两组,每组32例,对照组使用常规西医疗法,治疗组在西医疗法的基础上再配合苍牛防己黄芪汤治疗。观察并比较两组患者连续治疗1个月后的中医症候疗效、腹水复发率临床疗效差异。结果显示,治疗组的中医症候积分均明显低于对照组,治疗组的中医症候疗效和临床综合疗效明显优于对照组,治疗组的腹水复发率明显低于对照组。这表明,苍牛防己黄芪汤辅助西医基础治疗可有效改善乙肝肝硬化腹水患者中医症候症状,提升治疗效果,降低治疗后腹水复发率,为乙肝肝硬化腹水患者临床治疗提供参考。
[Abstract]:In order to investigate the clinical effect of Cangniu Fangji Huangqi decoction combined with western medicine on patients with ascites due to hepatitis B cirrhosis, 64 patients with ascites due to hepatitis B cirrhosis admitted in our hospital from May to October 2016 were randomly divided into two groups, 32 cases in each group. The control group was treated with routine western medicine, the treatment group was treated with Cangniu Fangji Huangqi decoction on the basis of western medicine therapy. To observe and compare the curative effect of TCM symptom and ascites recurrence rate after one month of continuous treatment between the two groups. The results showed that the scores of TCM symptoms in the treatment group were significantly lower than those in the control group, the curative effect of TCM syndrome and the clinical comprehensive curative effect in the treatment group were significantly better than those in the control group, and the recurrence rate of ascites in the treatment group was obviously lower than that in the control group. This indicates that Cangniu Fangji Huangqi decoction can effectively improve the symptoms of traditional Chinese medicine in patients with ascites due to liver cirrhosis, improve the therapeutic effect, reduce the recurrence rate of ascites after treatment, and provide a reference for the clinical treatment of patients with ascites due to hepatitis B cirrhosis.
【作者单位】：重庆中医院;
【基金】：重庆市自然科学基金(21201402048)资助
【分类号】：R512.62;R575.2

【相似文献】